CorridorAlpha
Get in touch
All reports

Investment strategy / Illustrative / 4 min read

A licence is not a moat: diligence beyond the permit.

A fictional acquisition shows why regulatory access, operating capability and investable value are different things.

For / Private equity & family offices

Written / 23 Oct 2026

Fictional case study. All named companies and countries in this article are invented. No real security, issuer or jurisdiction is being assessed. Not investment or legal advice.

The hypothetical acquisition

Project Canopy Nine is an invented private cannabis business. An investor is considering an acquisition based on its operating licence and distribution relationships. The illustrative seller presents regulatory scarcity as a durable competitive advantage. The diligence question is whether that advantage survives rule changes and stronger competition.

Three layers of evidence

First, establish licence validity, transfer restrictions, beneficial ownership and renewal conditions with qualified local counsel. Second, test the operating engine: customer retention, product quality, actual capacity utilisation and cash conversion. Third, map the balance sheet, contingent liabilities and funding required after completion.

A permit may provide market access without creating pricing power. Concentrated buyers, unreliable supply and weak controls can undermine a superficially attractive position. Independent verification matters more than a polished growth forecast.

Price uncertainty explicitly

The investment case should include downside scenarios for slower rollout, tighter product rules and lower wholesale prices. Milestone-based consideration or other negotiated protections may help allocate uncertainty, but they cannot repair a fundamentally weak business.

The committee should identify who can improve the asset, how much capital that requires and what exit routes remain credible. This fictional example is a diligence framework, not a valuation or recommendation concerning a real company.

The decision lens

Underwrite what survives a tougher market, not what looks scarce in today’s licensing regime.

Further perspectives

Equity research

Short selling: when the growth story outruns the cash.

Read article

Policy brief

Veloria: legalisation is a starting line, not a policy outcome.

Read article

Case study

Meridian Pension Trust: right-sizing a legacy cannabis allocation.

Read article

Case study

The Republic of Aravelle: a regulator’s market workshop.

Read article

Case study

Ostveld Capital: testing a plant-touching conviction.

Read article